Fundraising Fox

SR One Capital Management

Venture capitalActively deploying

Redwood City · Seed–Series B · 25 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

SR One invests in biotechnology companies with strong underlying fundamentals and clearly defined development pathways that employ novel approaches to addressing diseases. The firm provides strategic partnership, geographic reach, and regional expertise across its West Coast and London offices to support portfolio companies.

Invests inBiotechRedwood City

Source: firm website, verified Jul 21, 2026.

Stage
Seed–Series B
HQ
Redwood City, US
Instruments
Equity
AUM
$2.4B
Tracked investments
53

Team · 25 people

from the firm's website
Simeon J. George· Founder & CEO
Jake Nunn· Partner
Rajeev Dadoo· COO & Managing Partner
Amit Shah· Principal
Katarina Pance· Principal
Laetitia Schwab· Principal
Amit Mehta· Venture Partner - US Investments
Jake Bauer· Venture Partner - US Investments/New Company Creation
Matthew R. Patterson· Venture Partner - US Investments
Alicia Hasson· Executive Assistant
Ann Ng· Finance Director
Briana Wilson· Senior Administrative Assistant
Catalina Kazi· Legal & Compliance Counsel
Chris Chai· Operating Partner - Portfolio Capital Raising
Frances Benson· Chief of Staff & Manager, US Operations
Iqbal Mufti· Operating Partner - Portfolio Business Development
James Macadam· Chief Financial Officer
Jill Carroll· Operating Partner - Portfolio Value Creation
Lyla Youssef· Associate
Mahesh Kudari· Senior Associate
Mary Mirt· Administrative Assistant
Philip Habib· Head of Capital Partnering
Sasha Keough· General Counsel & Chief Compliance Officer
Tanya McGlashan· Manager, UK Operations
Viraj Pillai· Finance Director

What they invest in

from 2 of 53 portfolio companies

Biotech ×2AI & Machine Learning ×1Deep Tech ×1

HQs:United States×5

Investments · 53 tracked

founders shown can be your intro path
ADARx Pharmaceuticals
Addition Therapeutics
Airnexis Therapeutics Inc
Akamis Bio
Alumis
Ancora Biotech
Antag Therapeutics ApS
Arcellx
ARS Pharma
Asceneuron
Avalyn Pharma
Avenzo Therapeutics
Bicycle Therapeutics
Biotheryx
Charm Therapeutics, Inc.
Codify Therapeutics
Corxel Pharmaceuticals Limited
Crispr Therapeutics
Crystalys Therapeutics, Inc.
Design Therapeutics
Draig Therapeutics, Ltd
Dren Bio
Econic Biosciences
Elektrofi, Inc.
Fore Biotherapeutics
HotSpot Therapeutics
Immutrin Limited
Kala Bio
Kartos Therapeutics
Mineralys Therapeutics
Mission Therapeutics
Nimbus
Nkarta Inc
Nomic
Odyssey Therapeutics
Oruka Therapeutics Inc
Palleon Pharmaceuticals
Poplar Therapeutics
Pulmocide
Renalys
Rezo Therapeuticsrezotx.com

Rezo Therapeutics is a drug discovery and development company focused on oncology and inflammation therapeutic areas. The company combines artificial intelligence, chemistry, and high-throughput wet lab experiments to advance small molecule drug candidates from discovery through clinical development.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Nevan Krogan(Co-Founder)Sourav Bandyopadhyay(Co-Founder)Norbert Bischofberger(Co-Founder)Natalia Jura(Co-Founder)

Rezo Therapeutics
River Renal
Simcha Therapeutics
Simcha Therapeuticssimchatx.com

A drug discovery company advancing novel medicines targeting unexplored areas of immune biology, with a focus on cancer treatments.

Biotech

Telios Pharma
Topo Therapeutics, Inc.
Tranquis Therapeutics
Veradermics, Inc.
Vibrant Biomedicines
Windward Bio
Xap Therapeutics
Zenas Biopharma

Board seats · per SEC filings · 5

what is this? ⓘ
Veradermics, IncSEC filing

$30M raise · filed May 2026 · via Katarina Pance, Katarina Pance

Addition Therapeutics, Inc.SEC filing

$28M raise · filed Dec 2025 · via Laetitia Schwab, Matthew Patterson

Zenas BioPharma, Inc.SEC filing

$200.1M raise · filed May 2024 · via Jake Jacob Nunn

Addex Therapeutics Ltd.SEC filing

$3.7M raise · filed Apr 2023 · via Jake Nunn

Regulus Therapeutics Inc.SEC filing

$34.6M raise · filed Dec 2021 · via Jake R. Nunn

Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does SR One Capital Management invest at?
SR One Capital Management invests at the Seed, Series A, Series B stages.
What sectors does SR One Capital Management focus on?
SR One Capital Management focuses on Biotech.
Where is SR One Capital Management located?
SR One Capital Management is headquartered in Redwood City, US.

Similar investors

Andreessen Horowitz

a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.

B Capital Group

B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.

Bessemer Venture Partners

Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.

Breyer Capital

Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.

DCVC (Data Collective)

DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.

Featured in lists